PPW
ABBV icon

Pasadena Private Wealth’s AbbVie ABBV Stock Holding History

Pasadena Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
1,961
+7
+0.4% +$1.51K 0.06% 144
2026
Q1 		$425K Sell
1,954
-263
-12% -$58.3K 0.06% 142
2025
Q4 		$507K Buy
2,217
+907
+69% +$207K 0.07% 121
2025
Q3 		$303K Hold
1,310
– – 0.04% 159
2025
Q2 		$243K Sell
1,310
-64
-5% -$11.9K 0.04% 163
2025
Q1 		$288K Sell
1,374
-15
-1% -$2.92K 0.06% 150
2024
Q4 		$247K Sell
1,389
-155
-10% -$28.5K 0.05% 128
2024
Q3 		$305K Buy
1,544
+64
+4% +$11.9K 0.06% 114
2024
Q2 		$254K Sell
1,480
-20
-1% -$3.31K 0.06% 118
2024
Q1 		$273K Hold
1,500
– – 0.06% 113
2023
Q4 		$233K Sell
1,500
-18
-1% -$2.62K 0.06% 129
2023
Q3 		$226K Sell
1,518
-989
-39% -$145K 0.07% 81
2023
Q2 		$338K Buy
2,507
+88
+4% +$12.9K 0.1% 72
2023
Q1 		$386K Sell
2,419
-155
-6% -$23.7K 0.11% 65
2022
Q4 		$416K Sell
2,574
-13
-0.5% -$1.99K 0.13% 55
2022
Q3 		$347K Buy
+2,587
New +$371K 0.12% 58
2022
Q2 		– Sell
-1,362
Closed -$221K – 97
2022
Q1 		$221K Buy
+1,362
New +$198K 0.07% 82

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pasadena Private Wealth's ABBV Position: Q2 2026 in Review

Pasadena Private Wealth increased its AbbVie (ABBV) stake by 0.36% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,961 shares worth $494K. The position accounts for 0.06% of the portfolio, ranked #144.

Pasadena Private Wealth first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. The position peaked at $507K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pasadena Private Wealth held 1,961 shares of AbbVie worth $494K as of Q2 2026.
  • Pasadena Private Wealth bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.06% of Pasadena Private Wealth's portfolio in Q2 2026, its #144 holding.
  • Pasadena Private Wealth first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • Pasadena Private Wealth's AbbVie position peaked at $507K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pasadena Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.